Kellett Wealth Advisors LLC grew its stake in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 16.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 51,042 shares of the company’s stock after acquiring an additional 7,386 shares during the period. Procter & Gamble accounts for 5.6% of Kellett Wealth Advisors LLC’s holdings, making the stock its 5th largest position. Kellett Wealth Advisors LLC’s holdings in Procter & Gamble were worth $7,480,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds have also recently bought and sold shares of the stock. Emerald Advisors LLC grew its holdings in shares of Procter & Gamble by 1.8% during the 4th quarter. Emerald Advisors LLC now owns 3,775 shares of the company’s stock valued at $553,000 after purchasing an additional 65 shares during the last quarter. O Brien Wealth Partners LLC grew its holdings in Procter & Gamble by 3.3% in the 4th quarter. O Brien Wealth Partners LLC now owns 2,062 shares of the company’s stock worth $302,000 after acquiring an additional 65 shares during the last quarter. KFA Private Wealth Group LLC grew its holdings in Procter & Gamble by 2.2% in the 3rd quarter. KFA Private Wealth Group LLC now owns 3,054 shares of the company’s stock worth $445,000 after acquiring an additional 67 shares during the last quarter. Chemistry Wealth Management LLC grew its holdings in Procter & Gamble by 1.2% in the 4th quarter. Chemistry Wealth Management LLC now owns 5,839 shares of the company’s stock worth $856,000 after acquiring an additional 67 shares during the last quarter. Finally, Watchman Group Inc. grew its holdings in Procter & Gamble by 0.4% in the 3rd quarter. Watchman Group Inc. now owns 18,052 shares of the company’s stock worth $2,633,000 after acquiring an additional 68 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Procter & Gamble Stock Up 0.1 %
Procter & Gamble stock traded up $0.20 during trading hours on Thursday, hitting $157.16. The stock had a trading volume of 7,812,560 shares, compared to its average volume of 6,858,717. The company has a quick ratio of 0.44, a current ratio of 0.64 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $369.80 billion, a P/E ratio of 26.22, a price-to-earnings-growth ratio of 3.19 and a beta of 0.44. The Procter & Gamble Company has a 12-month low of $141.45 and a 12-month high of $163.14. The stock’s 50-day moving average price is $159.16 and its 200-day moving average price is $152.80.
Procter & Gamble Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be paid a $1.0065 dividend. The ex-dividend date is Thursday, April 18th. This is a positive change from Procter & Gamble’s previous quarterly dividend of $0.94. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.56%. Procter & Gamble’s payout ratio is currently 62.98%.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on the stock. Stifel Nicolaus raised their price target on shares of Procter & Gamble from $155.00 to $157.00 and gave the stock a “hold” rating in a report on Wednesday, January 24th. JPMorgan Chase & Co. cut their price target on shares of Procter & Gamble from $169.00 to $162.00 and set an “overweight” rating on the stock in a report on Thursday, January 18th. UBS Group lifted their target price on shares of Procter & Gamble from $172.00 to $178.00 and gave the company a “buy” rating in a research note on Wednesday, January 24th. Truist Financial raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and lifted their target price for the company from $160.00 to $175.00 in a research note on Monday, March 11th. Finally, Barclays lifted their target price on shares of Procter & Gamble from $165.00 to $168.00 and gave the company an “overweight” rating in a research note on Friday, April 12th. Seven analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat, Procter & Gamble presently has an average rating of “Moderate Buy” and an average target price of $168.53.
Get Our Latest Analysis on Procter & Gamble
Insider Transactions at Procter & Gamble
In other news, CEO Gary A. Coombe sold 22,000 shares of Procter & Gamble stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $161.32, for a total value of $3,549,040.00. Following the completion of the sale, the chief executive officer now directly owns 36,845 shares in the company, valued at $5,943,835.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, CEO Gary A. Coombe sold 22,000 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $161.32, for a total transaction of $3,549,040.00. Following the completion of the sale, the chief executive officer now directly owns 36,845 shares in the company, valued at $5,943,835.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO R. Alexandra Keith sold 776 shares of the business’s stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $158.11, for a total transaction of $122,693.36. Following the sale, the chief executive officer now owns 4,859 shares of the company’s stock, valued at $768,256.49. The disclosure for this sale can be found here. Insiders sold 279,063 shares of company stock worth $43,187,745 over the last three months. 0.17% of the stock is currently owned by company insiders.
About Procter & Gamble
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.
See Also
- Five stocks we like better than Procter & Gamble
- What Are Dividends? Buy the Best Dividend Stocks
- Comprehensive PepsiCo Stock Analysis
- 10 Best Airline Stocks to Buy
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- How to Calculate Options Profits
- Bear Market Funds to Watch This Year
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.